MSI

Clinical trials for MSI explained in plain language.

Never miss a new study

Get alerted when new MSI trials appear

Sign up with your email to follow new studies for MSI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Cancer combo trial pulled before it began

Disease control Terminated

This study was designed to test two immunotherapy drugs, monalizumab and MEDI5752, in people with MSI/dMMR metastatic cancer. These cancers have a genetic feature that makes them more responsive to immunotherapy. However, the trial was withdrawn before enrolling any participants,…

Matched conditions: MSI

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated May 17, 2026 03:43 UTC

MSI

Get alerted when new MSI trials appear

Cancer combo trial pulled before it began